A detailed history of Stephens Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Stephens Inc holds 3,334 shares of MRNA stock, worth $145,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,334
Previous 3,089 7.93%
Holding current value
$145,562
Previous $366,000 39.34%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$63.64 - $125.14 $15,591 - $30,659
245 Added 7.93%
3,334 $222,000
Q2 2024

Aug 06, 2024

SELL
$101.21 - $166.61 $39,876 - $65,644
-394 Reduced 11.31%
3,089 $366,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $13,232 - $17,893
155 Added 4.66%
3,483 $371,000
Q4 2023

Feb 13, 2024

SELL
$69.51 - $104.43 $14,458 - $21,721
-208 Reduced 5.88%
3,328 $330,000
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $1,928 - $2,532
-20 Reduced 0.56%
3,536 $365,000
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $11,850 - $16,053
-100 Reduced 2.74%
3,556 $432,000
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $5,426 - $7,880
40 Added 1.11%
3,656 $561,000
Q4 2022

Jan 25, 2023

BUY
$118.38 - $210.04 $34,330 - $60,911
290 Added 8.72%
3,616 $650,000
Q3 2022

Nov 02, 2022

BUY
$118.07 - $194.18 $11,570 - $19,029
98 Added 3.04%
3,326 $393,000
Q2 2022

Aug 03, 2022

BUY
$117.13 - $176.59 $13,352 - $20,131
114 Added 3.66%
3,228 $461,000
Q1 2022

May 04, 2022

BUY
$126.46 - $235.05 $24,406 - $45,364
193 Added 6.61%
3,114 $536,000
Q4 2021

Mar 07, 2022

BUY
$225.82 - $368.51 $56,455 - $92,127
250 Added 9.36%
2,921 $742,000
Q3 2021

Oct 27, 2021

SELL
$221.9 - $484.47 $15,533 - $33,912
-70 Reduced 2.55%
2,671 $1.03 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $6,495 - $11,749
-50 Reduced 1.79%
2,741 $644,000
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $65,508 - $111,588
-600 Reduced 17.69%
2,791 $365,000
Q4 2020

Feb 10, 2021

BUY
$65.74 - $169.86 $222,924 - $575,995
3,391 New
3,391 $354,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $17.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Stephens Inc Portfolio

Follow Stephens Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.